Prosecution Insights
Last updated: April 19, 2026

Keros Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18128465 METHODS OF USING ACTIVIN RECEPTOR TYPE II VARIANTS LEE, JIA-HAI 1658 Non-Final OA Mar 30, 2023
17945324 METHODS OF USING ACTIVIN RECEPTOR TYPE IIA VARIANTS BORGEEST, CHRISTINA M 1675 Final Rejection Sep 15, 2022

Managing Keros Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month